Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential Severe Asthma Hidden in UK Primary Care
Dermot Ryan, Heath Heatley, Liam G. Heaney, et al.
The Journal of Allergy and Clinical Immunology In Practice (2020) Vol. 9, Iss. 4, pp. 1612-1623.e9
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Cigarette Smoking and Asthma
Neil C. Thomson, Riccardo Polosa, Don D. Sin
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 11, pp. 2783-2797
Open Access | Times Cited: 84
Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study
Seyi Soremekun, Liam G. Heaney, Derek Skinner, et al.
Thorax (2022) Vol. 78, Iss. 7, pp. 643-652
Open Access | Times Cited: 60
Severe Asthma in a General Population Study: Prevalence and Clinical Characteristics
Lina Rönnebjerg, Malin Axelsson, Hannu Kankaanranta, et al.
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 1105-1115
Open Access | Times Cited: 59
Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma
Heath Heatley, Trung N. Tran, Arnaud Bourdin, et al.
Thorax (2022) Vol. 78, Iss. 9, pp. 860-867
Open Access | Times Cited: 33
Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group
Eugene R. Bleecker, Mona Al‐Ahmad, Leif Bjermer, et al.
World Allergy Organization Journal (2022) Vol. 15, Iss. 12, pp. 100726-100726
Open Access | Times Cited: 31
Questions in Mild Asthma: An Official American Thoracic Society Research Statement
Arjun Mohan, Njira Lugogo, Nicola A. Hanania, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 207, Iss. 11, pp. e77-e96
Open Access | Times Cited: 17
Prevalence and management of severe asthma in the Nordic countries: findings from the NORDSTAR cohort
Susanne Hansen, Anna von Bülow, Patrik Sandin, et al.
ERJ Open Research (2023) Vol. 9, Iss. 2, pp. 00687-2022
Open Access | Times Cited: 14
A simple and effective evidence-based approach to asthma management: ICS-formoterol reliever therapy
Mark L Levy, Richard Beasley, Bev Bostock, et al.
British Journal of General Practice (2024) Vol. 74, Iss. 739, pp. 86-89
Open Access | Times Cited: 5
Patient perspectives on the use of oral corticosteroids in asthma
Tonya Winders, Monica Fletcher, John Oppenheimer, et al.
Journal of Asthma (2025), pp. 1-29
Closed Access
Socioeconomic biases in asthma control and specialist referral of possible severe asthma
Kjell Erik Julius Håkansson, Vibeke Backer, Charlotte Suppli Ulrik
European Respiratory Journal (2021) Vol. 58, Iss. 6, pp. 2100741-2100741
Open Access | Times Cited: 30
Impact of Socioeconomic Status on Adult Patients with Asthma: A Population-Based Cohort Study from UK Primary Care
John Busby, David Price, Riyad Al‐Lehebi, et al.
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 1375-1388
Open Access | Times Cited: 29
Biologics in severe asthma: the role of real-world evidence from registries
Giovanni Paoletti, J. Pepys, Marta Casini, et al.
European Respiratory Review (2022) Vol. 31, Iss. 164, pp. 210278-210278
Open Access | Times Cited: 21
Benefits of specialist severe asthma management: demographic and geographic disparities
Charlene Redmond, Liam G. Heaney, Rekha Chaudhuri, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 6, pp. 2200660-2200660
Open Access | Times Cited: 21
The Korean Severe Asthma Registry (KoSAR): real world research in severe asthma
Sang‐Heon Kim, Hyun Lee, So‐Young Park, et al.
The Korean Journal of Internal Medicine (2022) Vol. 37, Iss. 2, pp. 249-260
Open Access | Times Cited: 19
A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of Asthma
John Haughney, Tonya Winders, Steve Holmes, et al.
Advances in Therapy (2023) Vol. 40, Iss. 6, pp. 2577-2594
Open Access | Times Cited: 11
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
Renaud Louis, Tim Harrison, Pascal Chanez, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 6, pp. 1759-1770.e7
Open Access | Times Cited: 10
Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care
Lola Loewenthal, John Busby, Ronald McDowell, et al.
Thorax (2023) Vol. 79, Iss. 5, pp. 403-411
Open Access | Times Cited: 9
Clinical review: The suggested management pathway for urticaria in primary care
Dermot Ryan, Luciana Kase Tanno, Elizabeth Angier, et al.
Clinical and Translational Allergy (2022) Vol. 12, Iss. 10
Open Access | Times Cited: 14
ERS/EAACI statement on adherence to international adult asthma guidelines
Alexander G. Mathioudakis, Olympia Tsilochristou, Ian M. Adcock, et al.
European Respiratory Review (2021) Vol. 30, Iss. 161, pp. 210132-210132
Open Access | Times Cited: 19
Documentation of comorbidities, lifestyle factors, and asthma management during primary care scheduled asthma contacts
Jaana Takala, Iida Vähätalo, Leena E. Tuomisto, et al.
npj Primary Care Respiratory Medicine (2024) Vol. 34, Iss. 1
Open Access | Times Cited: 2
Big Data Research on Severe Asthma
Sang Hyuk Kim, Youlim Kim
Tuberculosis & respiratory diseases (2024) Vol. 87, Iss. 3, pp. 213-220
Open Access | Times Cited: 2
Multivariate Cluster Analyses to Characterize Asthma Heterogeneity and Benralizumab Responsiveness
Xingnan Li, Paul Newbold, Rohit Katial, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 10, pp. 2732-2743
Open Access | Times Cited: 2
Prevalence and burden of difficult‐to‐treat and severe asthma in Australia: A national population survey
Sharon Davis, R Ampon, Leanne Poulos, et al.
Respirology (2024) Vol. 29, Iss. 8, pp. 685-693
Closed Access | Times Cited: 2
Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017–2022: An Analysis of the International Severe Asthma Registry
Tham Le, David Price, Clement Erhard, et al.
Journal of Asthma and Allergy (2024) Vol. Volume 17, pp. 1055-1069
Open Access | Times Cited: 2
Asthma Phenotyping in Primary Care: Applying the International Severe Asthma Registry Eosinophil Phenotype Algorithm Across All Asthma Severities
Marjan Kerkhof, Trung N. Tran, Riyad Al‐Lehebi, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 12, pp. 4353-4370
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top